February 15, 2012
Timothy J. Schroeder will present at the 7th Annual New York Stem Cell Summit, taking place February 21, 2012, where more than 30 of the world's leaders in this rapidly evolving industry will meet to discuss issues and opportunities in the stem cell market. Mr. Schroeder will present on the topic “Regenerative Medicine Clinical Research Trials – Are they Truly Different?”
Mr. Schroeder founded CTI more than a dozen years ago and is internationally recognized in the field of transplantation and regenerative medicine. During his 25 years of clinical, academic and industry experience, he has authored more than 200 peer-reviewed publications and has presented more than 300 papers at national and international conferences and was visiting faculty lecturer on approximately 175 occasions.
The New York Stem Cell Summit is focused on commercialization of cellular therapies. The summit will focus on learning about investment opportunities in the stem cell marketplace, groundbreaking stem cell products that physicians use today, and the growing market potential in terms of revenues, as well as describing how different companies are tackling the problem of getting these therapies from the lab to the bedside.